HomeHealth

Health

Wall Street’s Bull of The Day: Kura Oncology

Wall Street’s Bull of The Day: Kura Oncology

September 8, 2017

Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report

Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report

September 8, 2017

This Part of Bioverativ’s Pipeline Could Be a Key Driver For Long-Term Growth

This Part of Bioverativ’s Pipeline Could Be a Key Driver For Long-Term Growth

September 8, 2017

Gilead Sciences Stock Finally Sees New Uptrend Amid Multi-Year Lows

Gilead Sciences Stock Finally Sees New Uptrend Amid Multi-Year Lows

September 7, 2017

Why Sarepta Therapeutics Stock Rose 11% Today

Why Sarepta Therapeutics Stock Rose 11% Today

September 6, 2017

Lung Disease Drug Sends Insmed’s Stock Soaring

Lung Disease Drug Sends Insmed’s Stock Soaring

September 5, 2017

Pfizer’s Leukemia Drug Receives Green Light from FDA

Pfizer’s Leukemia Drug Receives Green Light from FDA

September 1, 2017

ImmunoGen had an Impressive 12% Climb Today

ImmunoGen had an Impressive 12% Climb Today

August 30, 2017

The Market Empties On Otonomy Inc. Stock

The Market Empties On Otonomy Inc. Stock

August 30, 2017

New Era of Cancer Treatment: Watch Out for Gilead

New Era of Cancer Treatment: Watch Out for Gilead

August 30, 2017

« 1 … 930 931 932 933 934 … 942 »